Dr. Christian is a regulatory toxicologist with over 30 years of experience in the contract pharmaceutical research industry. Prior to joining OSOD he served as the scientific lead for the ocular toxicology services offered at Covance/Labcorp Laboratories which included planning and directing nonclinical toxicology and pharmacology studies as senior study director. Brian is a diplomate of the American Board of Toxicology and has served on the Executive Committee of the Ocular Toxicology Specialty Section of the Society of Toxicology.
Brian Christian
Recent Publications
2021
Semiquantitative Methods for GFP Immunohistochemistry and In Situ Hybridization to Evaluate AAV Transduction of Mouse Retinal Cells Following Subretinal Injection
Toxicologic Pathology, 49(3), pp.537-543
2019
Normative Values for Multifocal ERGs Recorded from Cynomolgus Macaques in a Non-clinical Setting
In Investigative Ophthalmology & Visual Science (Vol. 60, No. 9)
2018
Ocular Safety of AAV2. 7m8-ChrimsonR-tdTomato (GS030-DP) following intravitreous injection and exposure to 595 nm LED light in blind rd1 mice
Investigative Ophthalmology & Visual Science, 59(9), pp.5658-5658
2017
Preliminary tolerability of iPSC-Derived RPE on PLGA scaffold implantation in RNU Nude Rats
American Society of Gene & Cell Therapy Annual Meeting. Mol Ther; 25(5S1)
2016
Variability in the Electroretinographic Response of Laboratory Animals
Investigative Ophthalmology & Visual Science, 57(12), pp.5766-5766
2015
Functional and Structural Effects of Subretinal Dose Delivery in Mice
Investigative Ophthalmology & Visual Science, 56(7), pp.245-245
2014
Gender Differences in Anesthetized Primate ERG and Full-field Flash VEP
Investigative Ophthalmology & Visual Science, 55(13), pp.5130-5130
2013
Emerging Imaging Technologies for Assessing Ocular Toxicity in Laboratory Animals
Molecular and Integrative Toxicology, Springer, New York, pp 53-121 (2013)
Inner Nuclear Layer (INL) Cystoid Spaces (Lacunae) Observed in Experimental Glaucoma and Axotomy in Non-Human Primates (NHPs)
Investigative Ophthalmology & Visual Science, 54(15), pp.4818-4818
Electrophysiologic Correlates of RNFL Thickness in Experimental Glaucoma
Investigative Ophthalmology & Visual Science, 54(15), pp.794-794
2011
Subretinal Administration of Fluorescent Microspheres in the Minipig
Investigative Ophthalmology & Visual Science, 52(14), pp.1358-1358.
Safety And Tolerability Of Retinostat®, A Lentiviral-vector Based Gene Therapy Product For The Treatment Of Wet Age-related Macular Degeneration, In Rabbits And Monkeys
Investigative Ophthalmology & Visual Science, 52(14), pp.488-488
Inter-ocular And Inter-subject Variability In The Full-field Electroretinograms Of Rabbits And Monkeys
Investigative Ophthalmology & Visual Science, 52(14), pp.703-703
2010
Supplemental Clock-Hour Fluorescein Angiography (FA) Scoring and Image Analysis of Laser-Induced Choroidal Neovascularization (CNV) Lesions in Cynomolgus Monkeys
Investigative Ophthalmology & Visual Science, 51(13), pp.6155-6155
INO-8875, an adenosine A1 agonist, lowers intraocular pressure through the conventional outflow pathway
Investigative Ophthalmology & Visual Science, 51(13), pp.3238-3238
Spectral domain OCT segmentation accuracy in monkeys
Investigative Ophthalmology & Visual Science, 51(13), pp.4401-4401
2009
Bilateral optic atrophy: a background finding in cynomolgus macaques used in toxicologic research
Investigative Ophthalmology & Visual Science, 50(13), pp.5344-5344
Continuous Monitoring of Intraocular Pressure in New Zealand White Rabbits Using Telemetry
Toxicologist Supplement (2009)
Ocular inflammation in cynomolgus macaques following intravenous administration of a human monoclonal antibody
International journal of toxicology, 28(1), pp.5-16
2008
Evaluation of EIAV Based Lentiviral Vectors Following Ocular Delivery in the Nonhuman Primate Model: Development of RetinoStat®
Investigative Ophthalmology & Visual Science, 49(13), pp.5340-5340
Pachymetry in New Zealand White Rabbits, Beagle Dogs, and Cynomolgus Monkeys.
Investigative Ophthalmology & Visual Science, 49(13), pp.645-645
Corneal endothelial cell density measurements using noncontact specular microscopy in rabbits, dogs and monkeys
Investigative Ophthalmology & Visual Science, 49(13), pp.2819-2819
Standardized Full-Field Electroretinography in Cynomolgus Monkeys
Investigative Ophthalmology & Visual Science, 49(13), pp.5816-5816
2006
Safety evaluation of intravitreal administration of VEGF trap in cynomolgus monkeys for 13 weeks.
Investigative Ophthalmology & Visual Science, 47(13), pp.1751-1751.
2003
Characterization of a Monkey Model of Laser-Induced Choroidal Neovascularization (CNV)
The Toxicologist, 72 (S-1): 311, (2003)
26-Week Intravitreal Injection Toxicity Study with rhuFab VEGF in Cynomolgus Monkeys with an 8-Week Recovery
Association for Research in Vision and Ophthalmology Annual Meeting. Invest Ophthalmol Vis Sci., 44 – electronic abstract (2003).
2001
Safety Evaluation of Differing Schedules of Intravitreal Administration of rhuFab VEGF in Cynomolgus Monkeys for 2 Months
Toxicologist, 60 (1):97 (2001).
2000
Safety Evaluation of Intravitreal Administration of rhuFab VEGF in Cynomolgus Monkeys for 3 Months
Invest Ophthalmol Vis Sci, 41 (4):S142 (2000).